Search results
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 18 hours agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
Moderna’s next-gen COVID vaccine shows non-inferiority to its current shot
WSAU Wausau· 18 hours ago(Reuters) -Moderna said on Thursday its next-generation COVID-19 vaccine candidate met its main goal...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 4 days agoThere could be a combined Covid-19 and flu shot in our future, although it won’t be ready for this...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 4 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Combined flu and Covid vaccine from Moderna shows positive results
dpa international via Yahoo News· 4 days agoThe results raise hopes the new vaccine could be approved by regulators this year, with the...
Moderna sees positive results in COVID-flu vaccine trial
The Hill via Yahoo News· 4 days agoModerna’s late-stage trial for its COVID-flu combination vaccine yielded positive results, the...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 3 days agoPharmaceutical company Moderna has announced that a combination vaccine it has been developing against flu and COVID-19</ ...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 2 days agoCovid-19 vaccine candidate. At this time, mRNA-1083 is poised to be the first Covid-19/influenza ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-...
The Joplin Globe· 18 hours agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-< ...